COA Conference Coverage
Featured Articles
(COA) Apr 12, 2018 – The Community Oncology Alliance (COA) today released the 2018 Community Oncology Practice Impact Report which tracks data on the changing landscape of cancer care in the United States.
Read Article
Latest Articles
April 24, 2018
April 16, 2018
April 16, 2018
April 13, 2018
April 13, 2018
April 12, 2018

OBR Tweets

Jan 25
Daniel Catenacci, MD, of @UChicagoMed elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020… https://t.co/SLFXcH9XHW

Jan 25
Manish Shah, MD, of @WeillCornell on the role of Cyramza in the treatment of gastric and esophageal cancers #GI20 https://t.co/83LT4SouTG

Jan 25
Daniel Catenacci, MD, of @UChicagoMed discusses margetuximab in the treatment of esophageal and gastric cancer #GI20 https://t.co/bKgtxzm0tl

Jan 25
Manish Shah, MD, of @WeillCornell regarding the use of liquid biopsy to diagnose and treat GI cancers #GI20 https://t.co/PgJcHQr2IZ

Jan 25
Sam Klempner, MD, of @harvardmed explains how circulating tumor DNA can be used to help determine therapy #GI20 https://t.co/xZwsm7PSW6

Jan 25
Hani Babiker, MD, of @UAZCancer elaborates on tumor treatment fields applying to GI malignancies #GI20 https://t.co/g8OENPsK7Y

Jan 25
Hani Babiker, MD, of @UAZCancer describes the setting of FDA approval on tumor treatment fields #GI20 https://t.co/Ytzc1MwAGM

Jan 25
Ahmed Kaseb, MD, of @MDAndersonNews on combining cabozantinib with checkpoint inhibitors for treatment of HCC #GI20 https://t.co/dd7RbGGru5

Jan 25
Ahmed Kaseb, MD, @MDAndersonNews on survival outcomes in the IMBRAVE 150 phase 3 study #GI20 https://t.co/3nSZN4yceY

Jan 25
Nevena Damjanov, MD, of @PennMedicine on impressions of the study of cabozantinib with in HCC patients #GI20 https://t.co/75BJaoY6je